This inventor holds 3 USPTO granted patents. Top assignees: Warner-Lambert Company, Basf Aktiengesellschaft. Active years: 1997-1999.
Company Filing History:
3 out of 2,538 
1 out of 10,816 
Years Active: 1997-1999
Title: John Lodge Gilmore: Innovator in Medical Imaging and Therapeutics
Introduction
John Lodge Gilmore is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical imaging and therapeutics, holding a total of 3 patents. His work focuses on innovative methods and compounds that address critical health issues.
Latest Patents
Gilmore's latest patents include a method of imaging amyloid deposits and hydroxamate inhibitors of interleukin-1β converting enzyme. The latter invention relates to compounds that inhibit interleukin-1β converting enzyme, which are crucial for treating conditions such as stroke, inflammatory diseases, septic shock, reperfusion injury, Alzheimer's disease, and shigellosis. Additionally, he has developed a pharmaceutically acceptable composition that contains these inhibitors.
Career Highlights
Throughout his career, Gilmore has worked with prominent companies, including Warner-Lambert Company and BASF Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in the development of innovative medical solutions.
Collaborations
Gilmore has collaborated with notable colleagues such as Bradley W. Caprathe and Sheryl Jeanne Hays. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
John Lodge Gilmore's contributions to medical imaging and therapeutics highlight his role as an influential inventor. His innovative patents and collaborations continue to impact the field positively.